Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[We must respect the anti-SARS-CoV-2 vaccine schedule without delay in cancer patients under treatment].
Barrière J, Audigier-Valette C, Borchiellini D, Hoch B, Castelnau O, Francois E, Gastaud L, Skaf R, Berdah JF, Marie W, Lescaut W, Peyrade F, Cluzeau T, Cassuto O, Carles M. Barrière J, et al. Among authors: castelnau o. Bull Cancer. 2021 Apr;108(4):341-342. doi: 10.1016/j.bulcan.2021.02.003. Epub 2021 Mar 5. Bull Cancer. 2021. PMID: 33741139 Free PMC article. French. No abstract available.
Cisplatin-docetaxel induction plus concurrent 3-D conformal radiotherapy and weekly chemotherapy for locally advanced non-small cell lung cancer patients: a phase II trial.
Poudenx M, Bondiau PY, Chamorey E, Venissac N, Otto J, Pourel N, Castelnau O, Tessier E, De Surmont Salasc B, Berdah JF, Pop D, Michel C, Mouroux J. Poudenx M, et al. Among authors: castelnau o. Oncology. 2012;83(6):321-8. doi: 10.1159/000342081. Epub 2012 Sep 13. Oncology. 2012. PMID: 22986621 Free article. Clinical Trial.
Prospective Multicenter Validation of the Detection of ALK Rearrangements of Circulating Tumor Cells for Noninvasive Longitudinal Management of Patients With Advanced NSCLC.
Ilié M, Mazières J, Chamorey E, Heeke S, Benzaquen J, Thamphya B, Boutros J, Tiotiu A, Fayada J, Cadranel J, Poudenx M, Moro-Sibilot D, Barlesi F, Thariat J, Clément-Duchêne C, Tomasini P, Hofman V, Marquette CH, Hofman P; STALKLUNG01 Study Consortium Investigators. Ilié M, et al. J Thorac Oncol. 2021 May;16(5):807-816. doi: 10.1016/j.jtho.2021.01.1617. Epub 2021 Feb 3. J Thorac Oncol. 2021. PMID: 33545389 Free article.
From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the French intergroup (IFCT) and the groupe d'Oncologie de langue francaise (GOLF).
Couraud S, Cortot AB, Greillier L, Gounant V, Mennecier B, Girard N, Besse B, Brouchet L, Castelnau O, Frappé P, Ferretti GR, Guittet L, Khalil A, Lefebure P, Laurent F, Liebart S, Molinier O, Quoix E, Revel MP, Stach B, Souquet PJ, Thomas P, Trédaniel J, Lemarié E, Zalcman G, Barlési F, Milleron B; French lung cancer screening statement taskforce; groupe d'Oncologie de langue française. Couraud S, et al. Among authors: castelnau o. Ann Oncol. 2013 Mar;24(3):586-97. doi: 10.1093/annonc/mds476. Epub 2012 Nov 7. Ann Oncol. 2013. PMID: 23136229 Free PMC article.
NGS analysis on tumor tissue and cfDNA for genotype-directed therapy in metastatic NSCLC patients. Between hope and hype?
Falk AT, Heeke S, Hofman V, Lespinet V, Ribeyre C, Bordone O, Poudenx M, Otto J, Garnier G, Castelnau O, Guigay J, Leroy S, Marquette CH, Hofman P, Ilié M. Falk AT, et al. Among authors: castelnau o. Expert Rev Anticancer Ther. 2017 Aug;17(8):681-685. doi: 10.1080/14737140.2017.1331736. Epub 2017 May 22. Expert Rev Anticancer Ther. 2017. PMID: 28511612
Phase II trial of paclitaxel and carboplatin in metastatic small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie study.
Thomas P, Castelnau O, Paillotin D, Léna H, Robinet G, Muir JF, Delaval P, Gouva S, Balmes P, Blanchon F, Perdu D, Poirier R, Pommier De Santi P, Penot-Ragon C, Kleisbauer JP. Thomas P, et al. Among authors: castelnau o. J Clin Oncol. 2001 Mar 1;19(5):1320-5. doi: 10.1200/JCO.2001.19.5.1320. J Clin Oncol. 2001. PMID: 11230474 Clinical Trial.
Critical Assessment in Routine Clinical Practice of Liquid Biopsy for EGFR Status Testing in Non-Small-Cell Lung Cancer: A Single-Laboratory Experience (LPCE, Nice, France).
Heeke S, Benzaquen J, Hofman V, Ilié M, Allegra M, Long-Mira E, Lassalle S, Tanga V, Salacroup C, Bonnetaud C, Fayada J, Gazoppi L, Ribeyre L, Castelnau O, Garnier G, Cattet F, Nanni I, de Fraipont F, Cohen C, Berthet JP, Leroy S, Poudenx M, Marquette CH, Denis MG, Barlesi F, Hofman P. Heeke S, et al. Among authors: castelnau o. Clin Lung Cancer. 2020 Jan;21(1):56-65.e8. doi: 10.1016/j.cllc.2019.07.010. Epub 2019 Aug 3. Clin Lung Cancer. 2020. PMID: 31519454
29 results